Posted by Michael Wonder on 26 Sep 2018
PHARMAC urged to subsidise cost prohibitive but 'highly effective' contraceptive option
26 September 2018 - The Mirena is a popular and effective contraceptive option but it's $340 price tag has been found to be cost-prohibitive for some Kiwi women.
There are renewed calls for a highly effective contraceptive to be subsidised by PHARMAC to ensure it's available for all women - regardless of economic status.
It's hoped new research, published this week in The Journal of Primary Health Care, will help in a push by Family Planning New Zealand to have PHARMAC fund a type of intrauterine device known commonly as Mirena.
